NYSE: IVZInvesco Ltd Stock
$15.37+0.10 (+0.65%)
Updated Apr 19, 2024
IVZ Price
$15.37
Fair Value Price
N/A
Market Cap
$6.90B
52 Week Low
$12.48
52 Week High
$18.71
P/E
-21.05x
P/B
0.47x
P/S
1.4x
PEG
N/A
Dividend Yield
5.2%
Revenue
$5.72B
Earnings
-$333.70M
Gross Margin
100%
Operating Margin
-5.82%
Profit Margin
-10%
Debt to Equity
0.89
Operating Cash Flow
$1B
Beta
1.56
Next Earnings
Apr 23, 2024
Ex-Dividend
N/A
Next Dividend
N/A
IVZ Overview
Invesco Ltd. is an independent investment management company operating under the Invesco, Trimark, Invesco Perpetual, WL Ross & Co, and Powershares brand names. The company offers asset classes including money market, balanced, equity, fixed income, and alternatives with a range of investment strategies across asset classes, investment styles, and geographies. Invesco's client base includes public and private entities, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. Invesco was created in 1978 and is headquartered in Atlanta, GA.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IVZ scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
IVZ is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IVZ is good value based on its book value relative to its share price (0.47x), compared to the US Asset Management industry average (2.3x)
P/B vs Industry Valuation
IVZ is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more IVZ due diligence checks available for Premium users.
Be the first to know about important IVZ news, forecast changes, insider trades & much more!
IVZ News
Valuation
IVZ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-21.05x
Industry
29.98x
Market
40.51x
IVZ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.47x
Industry
2.3x
IVZ is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
IVZ's financial health
Profit margin
Revenue
$1.4B
Net Income
-$742.3M
Profit Margin
-56.7%
IVZ's Earnings (EBIT) of -$332.90M... subscribe to Premium to read more.
Interest Coverage Financials
IVZ's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$28.9B
Liabilities
$13.0B
Debt to equity
0.89
IVZ's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IVZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$714.3M
Investing
-$261.6M
Financing
-$110.3M
IVZ's operating cash flow ($1.30B)... subscribe to Premium to read more.
Debt Coverage Financials
IVZ vs Asset Management Stocks
Invesco Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.